Comments
The Organisation of Pharmaceutical Producers of India has unanimously elected GlaxoSmithKline India chief A. Vaidheesh as its new President.
OPPI is a platform of multinational drug companies operating in India and Vaidheesh is GSK’s Vice-President (South Asia) & Managing Director, GlaxoSmithKline Pharmaceuticals Ltd. He takes over from Shailesh Ayyangar, Sanofi’s Managing Director (India) and Head of South Asia.
The multinational platform also elected four Vice-Presidents, Sharad Tyagi, Managing Director, Boehringer Ingelheim; Sanjiv Navangul, Managing Director, Janssen India (pharmaceutical companies of Johnson & Johnson Ltd); S. Sridhar, Managing Director, Pfizer Ltd and Anand Nambiar, Managing Director, Managing Director, Merck India Ltd.
OPPI’s new office-bearers take charge as a new pharmaceutical policy is in the works and different stakeholders take different and often opposing positions on intellectual property, drug pricing and access concerns on medicines.
On taking charge, the new OPPI president said in a statement that healthcare was moving towards “personalised” medicines and patient-care. And the pharmaceutical industry had an important role to play in delivering responsible healthcare.
Expressing OPPI's keeness in partnering with the Government, he said, a healthy country becomes a reality only when “science and research deliver new cures for unmet medical needs, thereby, fostering an environment of innovation.”
On the policy front, he said, “I am sure that the National Health Policy and the National IPR Policy will lead the way to better health outcomes. Along with an inclusive ecosystem, in the coming years, healthcare financing will also play its role in improving access to healthcare.”
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.